AYA Cancer Survivors

Cross-source consensus on AYA Cancer Survivors from 1 sources and 5 claims.

1 sources · 5 claims

Risks & contraindications

The most common cancer type in the exposed cohort was thyroid cancer at 21.2%, followed by Hodgkin lymphoma at 19%. — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study
In France, approximately 2,150 adolescent and young adults are newly diagnosed with cancer each year, more than half of whom are female. — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study
AYA cancer survivors face elevated gynaecological risks including increased exposure to STIs and HPV, treatment-induced endocrine dysfunction, fertility impairment, and heightened susceptibility to cervical dysplasia. — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study
Haematological malignancies were disproportionately common in the 15–19 age subgroup, accounting for 37.8% of cases. — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study
Research in countries other than France has documented poor gynaecological follow-up adherence among cancer survivors, driven by fear of re-diagnosis, a wish to move on from illness, and absence of perceived need. — Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study